The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo

Pediatric Research

Volumn 46, Issue 3, 1999, Pages 328-332

  Borgström, Per ^a   Hassan, Moustapha ^a,b   Wassberg, Erik ^c   Refai, Essam ^a   Jonsson, Cathrine ^b   Larsson, Stig A ^b   Jacobsson, Hans ^b   Kogner, Per ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; OCTREOTIDE; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOMEDIN A; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; NEUROBLASTOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SCINTIGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME; XENOGRAFT;

EID: 0032795044     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199909000-00014     Document Type: Article

References (31)

1. Kogner P 1995 Neuropeptides in neuroblastomas and ganglioneuromas. In: Nyberg F, Sharma HS, Wiesenfeld-Hallin Z (eds) Progress in Brain Research, Vol 104, Neuropeptides in the Spinal Cord. Elsevier, Amsterdam, pp 325-338
2. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495-1501
3. Reichlin S 1983 Somatostatin. N Engl J Med 309:1556-1563
4. Shulkes A 1994 Somatostatin: physiology and clinical applications. Ballière Clin Endoc 8:215-236
5. Schally AV 1988 Oncological applications of Somatostatin analogues. Cancer Res 48:6977-6985
6. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ 1996 Octreotide. N Engl J Med 334:246-254
7. O'Dorisio MS, Chen F, O'Dorisio TM, Wray D, Qualman SJ 1994 Characterization of Somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ 5:1-8
8. Maggi M, Baldi E, Finetti G, Franceschelli F, Brocchi A, Lanzillotti R, Serio M, Camboniu MG, Thiele CJ 1994 Identification, characterization, and biological activity of Somatostatin receptors in human neuroblastoma cell lines. Cancer Res 54:124-133
9. Candi E, Melino G, De Laurenzi V, Piacentini M, Guerrieri P, Spinedi A, Knight RA 1995 Tamoxifen and Somatostatin affect tumors by inducing apoptosis. Cancer Lett 96:141-145
10. Moertel CL, Reubi JC, Scheithauer BS, Schaid DJ, Kvols LK 1994 Expression of Somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 102:752-756
11. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC 1995 Somatostatin receptor scintigraphy. Nucl Med Ann 1:50
12. Sautter-Bihl ML, Dörr U, Schilling FH, Koscielniak E, Treuner J, Bihl H 1994 Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma. Semin Oncol 21(suppl 13):38-41
13. Schilling FH, Ambros PF, Bihl H, Martinsson T, Ambros IM, Borgström P, Jacobson H, Falkmer UG, Treuner J, Kogner P 1999 Somatostatin receptor expression in vivo is absent in neuroblastoma showing distal deletion of chromosome 1p and di/ tetraploid DNA content. Eur J Cancer (in press)
14. Kogner P, Borgström P, Bjellerup P, Schilling FH, Refai E, Jonsson C, Dominici C, Wassberg E, Bihl H, Jacobsson H, Theodorsson E, Hassan M 1997 Somatostatin in neuroblastoma and ganglioneuroma. Eur J Cancer 33:2084-2089
15. Kälkner KM, Janson ET, Nilsson S, Carlsson S, Öberg K, Westlin JE 1995 Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers. Cancer Res 55(suppl 23):5801s-5804s
16. Mattson MEK, Enberg G, Ruusala AI, Hall K, Pahlman S 1986 Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiation. J Cell Biol 102:1949-1954
17. Chanson P, Timsit J, Harris AG 1993 Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumors. Clin Pharmacokinet 25:375-391
18. Albers AR, O'Dorisio MS 1996 Clinical use of somatostatin analogues in paediatric oncology. Digestion 57(suppl 1):38-41
19. Kogner P, Theodorsson E, Björk O 1993 Neuropeptides indicating growth, difterentiation, and outcome in childhood neuroblastoma and ganglioneuroma. Clin Chem Enzyme Comms 5:289-294
20. Bjellerup P, Theodorsson E, Kogner P 1995 Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery. Eur J Cancer 31A:481-485
21. Biedler J, Helson L, Spengler BA 1973 Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
22. Wassberg E, Påhlman S, Westlin JE, Christofferson R 1997 The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr Res 41:327-333
23. Bang P, Eriksson U, Sara V, Wivall IL, Hall K 1991 Comparison of acid ethanol extraction and gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 124:620-629
24. 131I-VIP in the rat studied by gamma-camera. Nucl Med Biol 21:865-872
25. Sidell N 1982 Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68:589-596
26. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC 1991 Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 366:203-211
27. Cornaglia Ferraris P, Marottini GL, Ponzoni M 1992 Gamma-interferon and retinoic acid synergize in inhibiting the growth of human neuroblastoma cells in nude mice. Cancer Lett 61:215-220
28. Abemayor E 1992 The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells. Laryngoscope 102:1133-1149
29. Pence JC, Shorter NA 1993 The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation. Arch Surg 128:591-595
30. 1) octreotide scintigraphy in patients with carcinoid tumors: the predictive value for somatostatin analogue treatment. Eur J Endocrinol 131:577-581
31. Hillman N, Herranz L, Alvarez C, Martinez Olmos MA, Marco A, Gomes-Pan A 1998 Efficacy of octreotide in the regression of a metastatic carcinoid tumor despite negative imaging with In-111-pentetreotide. Exp Clin Endocrinol Diabetes 106:226-230